CN111903701A - A kind of veterinary fly-killing premix and its preparation method and application - Google Patents
A kind of veterinary fly-killing premix and its preparation method and application Download PDFInfo
- Publication number
- CN111903701A CN111903701A CN202010598698.7A CN202010598698A CN111903701A CN 111903701 A CN111903701 A CN 111903701A CN 202010598698 A CN202010598698 A CN 202010598698A CN 111903701 A CN111903701 A CN 111903701A
- Authority
- CN
- China
- Prior art keywords
- premix
- fly
- veterinary
- killing
- diflubenzuron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000005893 Diflubenzuron Substances 0.000 claims abstract description 52
- QQQYTWIFVNKMRW-UHFFFAOYSA-N diflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C=C1 QQQYTWIFVNKMRW-UHFFFAOYSA-N 0.000 claims abstract description 52
- 229940019503 diflubenzuron Drugs 0.000 claims abstract description 52
- 239000000843 powder Substances 0.000 claims abstract description 41
- 241000894006 Bacteria Species 0.000 claims abstract description 36
- 239000011230 binding agent Substances 0.000 claims abstract description 11
- 239000003085 diluting agent Substances 0.000 claims abstract description 11
- 239000000796 flavoring agent Substances 0.000 claims abstract description 11
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 11
- 239000000314 lubricant Substances 0.000 claims abstract description 9
- 239000000080 wetting agent Substances 0.000 claims abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 54
- 239000011812 mixed powder Substances 0.000 claims description 50
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 46
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 42
- 238000000227 grinding Methods 0.000 claims description 34
- 238000007873 sieving Methods 0.000 claims description 33
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 24
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 24
- 235000005822 corn Nutrition 0.000 claims description 24
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 22
- 235000019359 magnesium stearate Nutrition 0.000 claims description 21
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 18
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 18
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 18
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 18
- 241001465754 Metazoa Species 0.000 claims description 17
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 15
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 15
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 15
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 238000010298 pulverizing process Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 8
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 8
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 8
- 229920000053 polysorbate 80 Polymers 0.000 claims description 8
- 229940068968 polysorbate 80 Drugs 0.000 claims description 8
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 150000007524 organic acids Chemical group 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 108010011485 Aspartame Proteins 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- 239000000605 aspartame Substances 0.000 claims description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 5
- 229960003438 aspartame Drugs 0.000 claims description 5
- 235000010357 aspartame Nutrition 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 235000012054 meals Nutrition 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- -1 carrier Substances 0.000 claims description 2
- 241000209149 Zea Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 239000002689 soil Substances 0.000 description 33
- 240000008042 Zea mays Species 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 20
- 235000013312 flour Nutrition 0.000 description 19
- 239000003814 drug Substances 0.000 description 15
- 229940079593 drug Drugs 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 10
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 239000005891 Cyromazine Substances 0.000 description 9
- 229950000775 cyromazine Drugs 0.000 description 9
- 210000003608 fece Anatomy 0.000 description 8
- 235000010216 calcium carbonate Nutrition 0.000 description 7
- 244000144972 livestock Species 0.000 description 7
- 239000002917 insecticide Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 5
- 241000282887 Suidae Species 0.000 description 5
- 235000015165 citric acid Nutrition 0.000 description 5
- 235000021050 feed intake Nutrition 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 235000021051 daily weight gain Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000010871 livestock manure Substances 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 235000013594 poultry meat Nutrition 0.000 description 4
- 208000005374 Poisoning Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 231100000053 low toxicity Toxicity 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 229950008882 polysorbate Drugs 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 241000224483 Coccidia Species 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 229920000877 Melamine resin Polymers 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 238000003975 animal breeding Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000003630 growth substance Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 2
- 230000000243 photosynthetic effect Effects 0.000 description 2
- 238000003976 plant breeding Methods 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 235000013613 poultry product Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical class NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229940122041 Cholinesterase inhibitor Drugs 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000007974 melamines Chemical class 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000019617 pupation Effects 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 231100000916 relative toxicity Toxicity 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
- A01N47/34—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the groups, e.g. biuret; Thio analogues thereof; Urea-aldehyde condensation products
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/30—Microbial fungi; Substances produced thereby or obtained therefrom
- A01N63/32—Yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Biotechnology (AREA)
- Pest Control & Pesticides (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Fodder In General (AREA)
Abstract
本发明公开了一种兽用灭蝇预混剂及其制备方法和应用,以所述兽用灭蝇预混剂的总重量计,该兽用灭蝇预混剂包括:除虫脲5~10wt%、EM菌粉0.5~1.0wt%、稀释剂10~30wt%、矫味剂2~7wt%、载体40~70wt%、粘合剂5~10wt%、润湿剂1~5wt%和润滑剂2~8wt%。本发明制备出的预混剂疗效稳定、药效好、均一度高、稳定性好。The invention discloses a veterinary fly-killing premix and a preparation method and application thereof. Based on the total weight of the veterinary fly-killing premix, the veterinary fly-killing premix comprises: diflubenzuron 5- 10wt%, EM bacteria powder 0.5-1.0wt%, diluent 10-30wt%, flavoring agent 2-7wt%, carrier 40-70wt%, binder 5-10wt%, wetting agent 1-5wt% and lubricant agent 2 to 8wt%. The premix prepared by the invention has stable curative effect, good medicinal effect, high uniformity and good stability.
Description
技术领域technical field
本发明属于除虫剂技术领域,更具体地,涉及一种兽用灭蝇预混剂及 其制备方法和应用。The invention belongs to the technical field of insecticides, and more particularly, relates to a veterinary fly-killing premix and its preparation method and application.
背景技术Background technique
人们对畜禽养殖环境要求越来越高,但是苍蝇和蝇蛆一直是困扰养殖 场的一大难题。苍蝇是四害之一,其不但污染环境,而且是病毒和细菌的 携带者,人类的许多疾病都与苍蝇等蝇类有着直接关系。在养殖场,蝇类 的防治是一项艰巨而复杂的工作,药物控制是一项重要手段,但是绝大部 分的灭蝇剂毒性较大,使用后残留的药物对环境污染严重,甚至改变生态 系统。而且,大部分灭蝇剂都对人体有害,严重威胁人类的健康。People have higher and higher requirements for the livestock and poultry breeding environment, but flies and fly maggots have always been a major problem that plagued farms. Flies are one of the four pests. They not only pollute the environment, but also are carriers of viruses and bacteria. Many human diseases are directly related to flies such as flies. In farms, the prevention and control of flies is a arduous and complicated task, and drug control is an important means, but most of the flyicides are highly toxic, and the residual drugs after use cause serious environmental pollution and even change the ecology. system. Moreover, most flyicides are harmful to human body and seriously threaten human health.
目前,用于控制畜禽粪便内蝇蛆的药物主要有传统杀虫剂如有机磷类、 双甲脒和菊酯类杀虫剂,还有就是昆虫生长调节剂环丙氨嗪。但使用传统 杀虫剂控制畜禽粪便内的蝇蛆,存在一些弊端:如有机磷类杀虫剂和双甲 脒毒性较大,药残高,畜禽粪便再利用时存在中毒风险;菊酯类药物相对 毒性较低,但残效性差且蝇蛆耐药性产生较快。兽药上唯一专用的抗蝇蛆 药物是昆虫生长调节剂环丙氨嗪,虽然杀灭蝇蛆的效果很好,但已经使用了几十年,随着环丙氨嗪的使用时间越来越长,极有可能会出现耐环丙氨 嗪的蝇蛆,势必导致环丙氨嗪在饲料中添加量越来越大。环丙氨嗪的代谢 产物三聚氰胺的残留量也会随之增加。目前日本和欧洲等已经禁止在饲料 中添加环丙氨嗪,急需寻找一种可以与环丙氨嗪轮换使用,且对人畜安全, 低毒,环境友好的抗蝇蛆药物。At present, the drugs used to control fly maggots in livestock and poultry manure mainly include traditional insecticides such as organophosphorus, amitamidine and pyrethroid insecticides, as well as the insect growth regulator cyromazine. However, the use of traditional pesticides to control fly maggots in livestock and poultry manure has some drawbacks: for example, organophosphorus pesticides and amitimidine are highly toxic, with high drug residues, and there is a risk of poisoning when livestock and poultry manure is reused; pyrethroids The relative toxicity of the drug is low, but the residual effect is poor and the drug resistance of fly maggots develops quickly. The only special anti-fly maggot drug in veterinary medicine is the insect growth regulator cyromazine. Although the effect of killing flies is very good, it has been used for decades. As the use of cyromazine is getting longer and longer , it is very likely that cyromazine-resistant maggots will appear, which will inevitably lead to an increasing amount of cyromazine added to the feed. Residues of melamine, a metabolite of cyromazine, also increased. At present, Japan and Europe have banned the addition of cyromazine in the feed, and it is urgent to find an anti-fly maggot drug that can be used alternately with cyromazine, is safe for humans and animals, has low toxicity, and is environmentally friendly.
发明内容SUMMARY OF THE INVENTION
本发明的目的是克服现有技术的缺陷,提供一种新型兽用灭蝇预混剂 及其制备方法,该预混剂通过添加EM菌粉和除虫脲,使得制备的兽用灭 蝇预混剂具有良好的灭蝇蛆效果,且高效低毒。The object of the present invention is to overcome the defects of the prior art, and to provide a novel veterinary fly-killing premix and a preparation method thereof. The mixture has a good effect of killing flies and maggots, and has high efficiency and low toxicity.
为了实现上述目的,本发明的第一方面提供一种兽用灭蝇预混剂,以 所述兽用灭蝇预混剂的总重量计,该兽用灭蝇预混剂包括:除虫脲 5~10wt%、EM菌粉0.5~1.0wt%、稀释剂10~30wt%、矫味剂2~7wt%、载 体40~70wt%、粘合剂5~10wt%、润湿剂1~5wt%和润滑剂2~8wt%。In order to achieve the above object, a first aspect of the present invention provides a veterinary fly-killing premix, which, based on the total weight of the veterinary fly-killing premix, comprises: diflubenzuron 5~10wt%, EM fungus powder 0.5~1.0wt%, diluent 10~30wt%, flavoring agent 2~7wt%, carrier 40~70wt%, binder 5~10wt%, wetting agent 1~5wt% and lubricant 2-8wt%.
本发明中,EM菌是以光合细菌、乳酸菌、酵母菌和放线菌为主的10 个属80余个微生物复合而成的一种微生物菌制剂,一般包括光合菌、酵母 菌、乳酸菌等等有益菌类。可用于食品添加,养殖病害防治,土壤改良、 生根壮苗、污水治理等等。In the present invention, EM bacteria is a kind of microbial bacteria preparation composed of more than 80 microorganisms in 10 genera, mainly including photosynthetic bacteria, lactic acid bacteria, yeast bacteria and actinomycetes, generally including photosynthetic bacteria, yeast bacteria, lactic acid bacteria, etc. Beneficial bacteria. It can be used for food addition, breeding disease control, soil improvement, rooting and strong seedlings, sewage treatment and so on.
除虫脲是一种特异性低毒杀虫剂,属苯甲酸基苯基脲类除虫剂。安全 性高,大鼠经口LD50>5000mg/kg。其杀虫机理和过去的常规杀虫剂截然 不同,既不是神经毒剂,也不是胆碱酯酶抑制剂,它的主要作用是抑制昆 虫表皮的几丁质合成,同时对脂肪体、咽侧体等内分泌和腺体又有损伤破 坏作用,从而妨碍昆虫的顺利蜕皮变态。主要作用方式是胃毒和触杀。害 虫取食后造成积累性中毒,由于缺乏几丁质,幼虫不能形成新表皮,蜕皮 困难,化蛹受阻;成虫难以羽化、产卵;卵不能正常发育、孵化的幼虫表 皮缺乏硬度而死亡,从而影响害虫整个世代,这就是除虫脲的优点之所 在。Diflubenzuron is a specific low-toxicity insecticide, belonging to the benzoic acid-based phenylurea class of insecticides. It has high safety, and the oral LD 50 of rats is more than 5000mg/kg. Its insecticidal mechanism is completely different from that of conventional insecticides in the past. It is neither a nerve agent nor a cholinesterase inhibitor. Its main function is to inhibit the synthesis of chitin in the epidermis of insects, and it also affects the fat body and pharyngeal body. And other endocrine and glands have damage and destruction, thus hindering the smooth molting of insects metamorphosis. The main mode of action is stomach poisoning and contact killing. Accumulated poisoning caused by insects feeding. Due to the lack of chitin, larvae cannot form new epidermis, molting is difficult, and pupation is blocked; adults are difficult to emerge and lay eggs; eggs cannot develop normally, and the hatched larvae's epidermis lack hardness and die, thus It affects the entire generation of pests, which is the advantage of diflubenzuron.
本发明的兽用灭蝇预混剂,其将EM菌粉和除虫脲配合使用,两者一 起发挥作用,在使用除虫脲的同时添加一定量的EM菌粉可大大提高防蝇 控蝇的效果,可以减少除虫脲的使用对动物机体和环境的影响,使得灭蝇 剂的杀蝇控蝇效果大大提升,有效减少了除虫脲的使用量,降低药物污染 和残留,而且还具有增强动物免疫力、抗病力,增进动物健康,有效控制 预防痢疾、球虫、大肠杆菌及呼吸系统疾病发生,促进动物生长,提高日 增重,缩短饲养时间,减少、甚至不用抗生素,生产绿色畜禽产品等优 势,在动植物养殖业具有广阔的应用前景。In the veterinary fly-killing premix of the present invention, EM bacteria powder and diflubenzuron are used together, and the two play a role together. Adding a certain amount of EM bacteria powder while using diflubenzuron can greatly improve the control of flies. The effect of diflubenzuron can reduce the impact of the use of diflubenzuron on the animal body and the environment, which greatly improves the fly control effect of the flyicide, effectively reduces the use of diflubenzuron, reduces drug pollution and residues, and has Enhance animal immunity, disease resistance, improve animal health, effectively control and prevent dysentery, coccidia, Escherichia coli and respiratory diseases, promote animal growth, increase daily weight gain, shorten feeding time, reduce or even eliminate antibiotics, and produce green The advantages of livestock and poultry products have broad application prospects in the animal and plant breeding industry.
预混剂是一种临床应用方便,饲养工人乐于使用的剂型,特别适用于 整群动物的预防性治疗,如果将杀虫药制成预混剂,直接添加到饲料中投 喂,不但省时省力,而且可以避免用药时对动物造成的应激。Premix is a kind of formulation that is convenient for clinical application and easy to be used by livestock workers. It is especially suitable for the preventive treatment of whole animals. If the pesticide is made into premix and added directly to the feed, it will not only save time It is labor-saving and can avoid the stress caused to the animal when the drug is administered.
在兽药预混剂中,药品的安全性和药效与均一性有密切的关系,预混 剂产品的均一性是确保产品质量的重要因素,而产品的均一性与辅料的选 择和制备工艺有密切的关系,辅料是药物制剂中除主药以外的附加物,除 了赋性、充当载体、提高稳定性外,还具有增溶、助溶、缓控释等重要功 能,与提高药物的疗效、降低不良反应有很大的关系,选择合适的辅料不 仅关系到预混剂的均一性、流动性、稳定性,还关系到预混剂的安全性和 药物的疗效。In veterinary drug premixes, the safety and efficacy of the drug are closely related to the homogeneity. The homogeneity of the premix product is an important factor to ensure product quality, and the homogeneity of the product is closely related to the selection and preparation of excipients. In addition to excipients, acting as carriers, and improving stability, excipients are additions to pharmaceutical preparations. They also have important functions such as solubilization, solubilization, and sustained and controlled release. Adverse reactions have a great relationship, and the selection of suitable excipients is not only related to the homogeneity, fluidity and stability of the premix, but also to the safety of the premix and the efficacy of the drug.
根据本发明,优选地,所述稀释剂为微晶纤维素和/或乳糖。According to the present invention, preferably, the diluent is microcrystalline cellulose and/or lactose.
稀释剂一般情况下,是用来填充重量和体积,也可以同时起到粘合剂 的作用;本发明采用特定的稀释剂可以保证预混物料的流动性适中,太光 滑则不能吸附到载体上,太粗糙则导致分散不均匀。In general, the diluent is used to fill the weight and volume, and can also play the role of a binder at the same time; the specific diluent used in the present invention can ensure that the fluidity of the premixed material is moderate, and if it is too smooth, it cannot be adsorbed on the carrier. , too rough will lead to uneven dispersion.
根据本发明,优选地,所述矫味剂为有机酸和/或阿斯巴甜,所述有机 酸优选为枸橼酸。According to the present invention, preferably, the flavoring agent is an organic acid and/or aspartame, and the organic acid is preferably citric acid.
本发明的矫味剂一方面为用以改善或屏蔽药物异味的药用辅料,另一 方面是采用有机酸矫味剂在一定程度上可以增加除虫脲的溶解性。On the one hand, the flavoring agent of the present invention is the medicinal adjuvant in order to improve or shield the peculiar smell of medicine, and on the other hand, the dissolubility of diflubenzuron can be increased to a certain extent by adopting the organic acid flavoring agent.
根据本发明,优选地,所述载体为玉米粉和碳酸钙,所述玉米粉和碳 酸钙的重量比为1-3:1。According to the present invention, preferably, the carrier is corn meal and calcium carbonate, and the weight ratio of the corn meal and calcium carbonate is 1-3:1.
载体是指能接受和承载活性成分的可饲物料,本发明的载体能起到稀 释和提高流动性的作用使得活性成分更易于分布到饲料中。The carrier refers to the feedable material that can receive and carry the active ingredient, and the carrier of the present invention can play the role of dilution and improve the fluidity, so that the active ingredient can be easily distributed into the feed.
根据本发明,优选地,所述粘合剂为羧甲基纤维素钠和/或聚乙烯醇。According to the present invention, preferably, the binder is sodium carboxymethyl cellulose and/or polyvinyl alcohol.
粘合剂是使无粘性或粘性小的物料聚集粘接成颗粒或压缩成型的具有 粘性的固体粉末或粘稠液体。因为除虫脲的溶解性差,不能通过水溶后使 用,限制了给药方式。本发明通过加入粘合剂和其他辅料使得除虫脲预混 剂既可以混入饲料给药,也可以混入饮水给药。Binders are viscous solid powders or viscous liquids that aggregate and bond non-viscous or low-viscosity materials into granules or compression molding. Due to the poor solubility of diflubenzuron, it cannot be used after being dissolved in water, which limits the way of administration. In the present invention, by adding binder and other auxiliary materials, the diflubenzuron premix can be mixed into feed for administration and also can be mixed into drinking water for administration.
根据本发明,优选地,所述润湿剂为聚山梨醇酯80和/或无水乙醇。According to the present invention, preferably, the wetting agent is polysorbate 80 and/or absolute ethanol.
根据本发明,优选地,所述润滑剂为硬脂酸镁。According to the present invention, preferably, the lubricant is magnesium stearate.
本发明的第二方面提供上述兽用灭蝇预混剂的制备方法,该制备方法 包括:A second aspect of the present invention provides the preparation method of the above-mentioned veterinary fly-killing premix, the preparation method comprising:
(1)将除虫脲、EM菌粉、稀释剂、矫味剂、载体、粘合剂和润滑剂 分别进行研磨、过筛;(1) Diflubenzuron, EM bacteria powder, diluent, flavoring agent, carrier, adhesive and lubricant are respectively ground and sieved;
(2)将所述研磨、过筛后的除虫脲和稀释剂,进行粉碎混合,得到第 一混合粉末;(2) diflubenzuron and the diluent after described grinding, sieving are pulverized and mixed to obtain the first mixed powder;
(3)将所述第一混合粉末与所述研磨、过筛后的矫味剂进行粉碎混 合,得到第二混合粉末;(3) the first mixed powder is pulverized and mixed with the flavoring agent after the grinding and sieving to obtain the second mixed powder;
(4)将所述第二混合粉末与所述研磨、过筛后的载体进行粉碎混合, 得到第三混合粉末;(4) pulverizing and mixing the second mixed powder and the ground and sieved carrier to obtain a third mixed powder;
(5)将所述第三混合粉末和EM菌粉按照等量递增法混合均匀,然后 与润湿剂、所述研磨、过筛后的润滑剂和粘合剂混合均匀,即得所述预混 剂。(5) the third mixed powder and the EM bacteria powder are mixed uniformly according to the equal increment method, and then mixed uniformly with the wetting agent, the lubricant and the binder after the grinding and sieving to obtain the pre- mixture.
在兽药预混剂的有效成分与辅料的混合过程中,一方面搅拌机械对物 料起着混合作用,另一方面由于被混合物料粒子之间存在相对密度、粒 度、表面特性的差异,在运动时必定也产生着自动分级,自动分级使物料 的均匀状态受到破坏,因此本发明对于物料的混合方式和混合顺序做了进 一步的限定,极大程度上提升了混合物料的均一性、稳定性和安全性。In the process of mixing the active ingredients and excipients of veterinary drug premixes, on the one hand, the stirring machine plays a role in mixing the materials; There must also be automatic grading, which destroys the uniform state of the material. Therefore, the present invention further limits the mixing method and mixing sequence of the material, which greatly improves the uniformity, stability and safety of the mixed material. sex.
根据本发明,优选地,步骤(1)中,所述研磨的时间为5-10min,所 述研磨、过筛后的粒径不大于80目;According to the present invention, preferably, in step (1), the time of described grinding is 5-10min, and the particle diameter after described grinding and sieving is not more than 80 meshes;
步骤(2)中,所述粉碎混合在气流粉碎机中进行,所述气流粉碎机的 进给速度为3.0-5.0kg/h,气压为2.5×105-4.5×105Pa;所述第一混合粉末的 粒径为D90≤30μm;In step (2), the pulverization and mixing are carried out in a jet mill, the feed speed of the jet mill is 3.0-5.0kg/h, and the air pressure is 2.5×10 5 -4.5×10 5 Pa; The particle size of the mixed powder is D90≤30μm;
步骤(3)中,所述粉碎混合在球磨机中进行,所述粉碎混合的时间为 10-15min;In step (3), described pulverization and mixing are carried out in a ball mill, and the time of described pulverization and mixing is 10-15min;
步骤(4)中,所述粉碎混合在球磨机中进行,所述粉碎混合的时间为 15-25min;In step (4), the pulverization and mixing are carried out in a ball mill, and the time for pulverization and mixing is 15-25min;
步骤(5)中,在制粒机中进行混合。In step (5), mixing is performed in a granulator.
在预混剂生产过程中,制备工艺直接影响产品的均一性,不仅要求准 确配料,还必须保证有效成分在整批预混剂中均匀分布,制备工艺中设备、 物料物性、进料顺序、混合时间都是很重要的因素。In the production process of premix, the preparation process directly affects the uniformity of the product. Not only accurate ingredients are required, but also effective ingredients must be uniformly distributed in the whole batch of premix. Equipment, material properties, feeding sequence, mixing Time is an important factor.
本发明的第三方面提供上述兽用灭蝇预混剂在动物饲料中的应用。The third aspect of the present invention provides the application of the above-mentioned veterinary fly-killing premix in animal feed.
本发明的技术方案具有如下有益效果:The technical scheme of the present invention has the following beneficial effects:
(1)本发明的预混剂含有EM菌粉和除虫脲,其将EM菌粉和除虫脲 配合使用,两者一起发挥作用,在使用除虫脲的同时添加一定量的EM菌 粉可大大提高防蝇控蝇的效果,可以减少除虫脲的使用对动物机体和环境 的影响,使得灭蝇剂的杀蝇控蝇效果大大提升,有效减少了除虫脲的使用 量,降低药物污染和残留,而且还具有增强动物免疫力、抗病力,增进动 物健康,有效控制预防痢疾、球虫、大肠杆菌及呼吸系统疾病发生,促进 动物生长,提高日增重,缩短饲养时间,减少、甚至不用抗生素,生产绿 色畜禽产品等优势,在动植物养殖业具有广阔的应用前景。(1) Premix of the present invention contains EM bacterium powder and diflubenzuron, and it uses EM bacterium powder and diflubenzuron in combination, and both play a role together, and add a certain amount of EM bacterium powder while using diflubenzuron It can greatly improve the effect of fly control and fly control, and can reduce the impact of the use of diflubenzuron on the animal body and the environment, which greatly improves the fly control effect of the fly control agent, effectively reduces the use of diflubenzuron, and reduces the use of drugs. Pollution and residues, but also enhance animal immunity, disease resistance, improve animal health, effectively control and prevent dysentery, coccidia, Escherichia coli and respiratory diseases, promote animal growth, increase daily weight gain, shorten feeding time, reduce , Even without antibiotics, the advantages of producing green livestock and poultry products have broad application prospects in the animal and plant breeding industry.
(2)本发明的预混剂中添加了粘合剂和有机酸,増加了除虫脲的溶解 性。(2) binder and organic acid are added in the premix of the present invention, and the solubility of diflubenzuron is increased.
(3)本发明的制备方法的预处理过程中,条件温和,属于物理变化, 不存在化学反应,除虫脲收率可保持100%,无任何损失。(3) In the pretreatment process of the preparation method of the present invention, the conditions are mild and belong to physical changes, and there is no chemical reaction, and the yield of diflubenzuron can be maintained at 100% without any loss.
(4)本发明的预混剂制备过程中采用微粉化技术,除虫脲的粒径降低 了,增加了除虫脲的溶解性,使得除虫脲预混剂既可以混入饲料给药,也 可以混入饮水给药。(4) The micronization technology is adopted in the preparation process of the premix of the present invention, the particle size of diflubenzuron is reduced, and the solubility of diflubenzuron is increased, so that the premix of diflubenzuron can be mixed into the feed for administration, and also Can be mixed with drinking water for administration.
(5)本发明的生产制备工艺简便可行、质量可控、操作简单、成本 低、污染小。(5) The production and preparation process of the present invention is simple and feasible, the quality is controllable, the operation is simple, the cost is low, and the pollution is small.
(6)本发明制备出的预混剂疗效稳定、药效好、均一度高、稳定性 好。(6) The premix prepared by the present invention has stable curative effect, good efficacy, high uniformity and good stability.
本发明的其它特征和优点将在随后具体实施方式部分予以详细说明。Other features and advantages of the present invention will be described in detail in the detailed description that follows.
具体实施方式Detailed ways
下面将更详细地描述本发明的优选实施方式。虽然以下描述了本发明 的优选实施方式,然而应该理解,可以以各种形式实现本发明而不应被这 里阐述的实施方式所限制。相反,提供这些实施方式是为了使本发明更加 透彻和完整,并且能够将本发明的范围完整地传达给本领域的技术人员。Preferred embodiments of the present invention will be described in more detail below. While preferred embodiments of the present invention are described below, it should be understood that the present invention may be embodied in various forms and should not be limited by the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art.
以各实施例和对比例所用的EM菌粉购自沧州市东方兽药有限公司。The EM bacteria powder used in each example and the comparative example was purchased from Cangzhou Dongfang Veterinary Medicine Co., Ltd.
实施例1Example 1
本实施例提供一种兽用灭蝇预混剂,该兽用灭蝇预混剂由如下组分组 成:除虫脲67g、EM菌粉6.7g、微晶纤维素200g、枸橼酸50g、玉米粉300g、 碳酸钙226.3g、羧甲基纤维素钠75g、聚山梨醇酯80 25g和硬脂酸镁50g;This embodiment provides a veterinary fly-killing premix, which is composed of the following components: diflubenzuron 67g, EM bacterial powder 6.7g, microcrystalline cellulose 200g, citric acid 50g, Corn flour 300g, calcium carbonate 226.3g, sodium carboxymethyl cellulose 75g, polysorbate 80 25g and magnesium stearate 50g;
具体制备方法为:(1)将处方量的除虫脲、EM菌粉、微晶纤维素、枸 橼酸、玉米粉、碳酸钙、羧甲基纤维素钠和硬脂酸镁分别进行研磨10min 后过80目筛备用;The specific preparation method is: (1) Diflubenzuron, EM bacterial powder, microcrystalline cellulose, citric acid, corn flour, calcium carbonate, sodium carboxymethyl cellulose and magnesium stearate of the recipe quantity are respectively ground for 10min After passing through an 80-mesh sieve, it is ready for use;
(2)将研磨、过筛后的除虫脲和微晶纤维素通过干氮气输入到气流粉 碎机中(气流粉碎机进给速度是5.0kg/h,气压4.5×105Pa),得粒径D90≤ 30μm第一混合粉末;(2) The diflubenzuron and microcrystalline cellulose after grinding and sieving are input into the jet mill through dry nitrogen (the feed rate of the jet mill is 5.0kg/h, the air pressure is 4.5×10 5 Pa), and the pellets are obtained The first mixed powder with diameter D90≤30μm;
(3)将所述第一混合粉末中加入研磨、过筛后的枸橼酸在球磨机中粉 碎混合15min,得到第二混合粉末;(3) the citric acid after grinding, sieving is added in the described first mixed powder and pulverized and mixed 15min in a ball mill to obtain the second mixed powder;
(4)将所述第二混合粉末中加入研磨、过筛后的玉米粉和碳酸钙在球 磨机中粉碎混合25min,得到第三混合粉末;(4) the corn flour after grinding, sieving and calcium carbonate are added to the second mixed powder and pulverized and mixed 25min in a ball mill to obtain the third mixed powder;
5)将所述第三混合粉末和EM菌粉按照等量递增法投入制粒机中混合 均匀,加入研磨、过筛后的硬脂酸镁和羧甲基纤维素钠,喷入聚山梨醇酯 80后混合均匀,即得兽用灭蝇预混剂。5) The third mixed powder and EM bacteria powder are dropped into the granulator according to the equal increment method and mixed, add the magnesium stearate and sodium carboxymethyl cellulose after grinding and sieving, and spray into the polysorbate After ester 80, mix evenly to obtain veterinary fly-killing premix.
实施例2Example 2
本实施例提供一种兽用灭蝇预混剂,该兽用灭蝇预混剂由如下组分组 成:除虫脲67g、EM菌粉6.7g、微晶纤维素250g、枸橼酸50g、玉米粉250g、 碳酸钙226.3g、羧甲基纤维素钠75g、无水乙醇25g和硬脂酸镁50g;This embodiment provides a veterinary fly-killing premix, which is composed of the following components: diflubenzuron 67g, EM bacterial powder 6.7g, microcrystalline cellulose 250g, citric acid 50g, 250g corn flour, 226.3g calcium carbonate, 75g sodium carboxymethyl cellulose, 25g absolute ethanol and 50g magnesium stearate;
具体制备方法为:(1)将处方量的除虫脲、EM菌粉、微晶纤维素、枸 橼酸、玉米粉、碳酸钙、羧甲基纤维素钠和硬脂酸镁分别进行研磨10min 后过80目筛备用;The specific preparation method is: (1) Diflubenzuron, EM bacterial powder, microcrystalline cellulose, citric acid, corn flour, calcium carbonate, sodium carboxymethyl cellulose and magnesium stearate of the recipe quantity are respectively ground for 10min After passing through an 80-mesh sieve, it is ready for use;
(2)将研磨、过筛后的除虫脲和微晶纤维素通过干氮气输入到气流粉 碎机中(气流粉碎机进给速度是5.0kg/h,气压4.5×105Pa),得粒径D90≤ 30μm第一混合粉末;(2) The diflubenzuron and microcrystalline cellulose after grinding and sieving are input into the jet mill through dry nitrogen (the feed rate of the jet mill is 5.0kg/h, the air pressure is 4.5×10 5 Pa), and the pellets are obtained The first mixed powder with diameter D90≤30μm;
(3)将所述第一混合粉末中加入研磨、过筛后的枸橼酸在球磨机中粉 碎混合15min,得到第二混合粉末;(3) the citric acid after grinding, sieving is added in the described first mixed powder and pulverized and mixed 15min in a ball mill to obtain the second mixed powder;
(4)将所述第二混合粉末中加入研磨、过筛后的玉米粉和碳酸钙在球 磨机中粉碎混合25min,得到第三混合粉末;(4) the corn flour after grinding, sieving and calcium carbonate are added to the second mixed powder and pulverized and mixed 25min in a ball mill to obtain the third mixed powder;
5)将所述第三混合粉末和EM菌粉按照等量递增法投入制粒机中混合 均匀,加入研磨、过筛后的硬脂酸镁和羧甲基纤维素钠,喷入无水乙醇后 混合均匀,即得兽用灭蝇预混剂。5) The third mixed powder and EM bacteria powder are dropped into the granulator according to the equal increment method and mixed, add the magnesium stearate and sodium carboxymethyl cellulose after grinding and sieving, and spray into dehydrated alcohol After mixing evenly, the veterinary fly-killing premix is obtained.
实施例3Example 3
本实施例提供一种兽用灭蝇预混剂,该兽用灭蝇预混剂由如下组分组 成:除虫脲67g、EM菌粉6.7g、微晶纤维素200g、阿斯巴甜50g、玉米粉 300g、碳酸钙226.3g、羧甲基纤维素钠75g、聚山梨醇酯80 25g和硬脂酸 镁50g;This embodiment provides a veterinary fly-killing premix, which is composed of the following components: diflubenzuron 67g, EM bacterial powder 6.7g, microcrystalline cellulose 200g, aspartame 50g , corn flour 300g, calcium carbonate 226.3g, sodium carboxymethyl cellulose 75g, polysorbate 80 25g and magnesium stearate 50g;
具体制备方法为:(1)将处方量的除虫脲、EM菌粉、微晶纤维素、阿 斯巴甜、玉米粉、碳酸钙、羧甲基纤维素钠和硬脂酸镁分别进行研磨10min 后过80目筛备用;The concrete preparation method is as follows: (1) Diflubenzuron, EM bacterial powder, microcrystalline cellulose, aspartame, corn flour, calcium carbonate, sodium carboxymethyl cellulose and magnesium stearate of recipe quantity are ground respectively After 10 minutes, pass through an 80-mesh sieve for use;
(2)将研磨、过筛后的除虫脲和微晶纤维素通过干氮气输入到气流粉 碎机中(气流粉碎机进给速度是5.0kg/h,气压4.5×105Pa),得粒径D90≤ 30μm第一混合粉末;(2) The diflubenzuron and microcrystalline cellulose after grinding and sieving are input into the jet mill through dry nitrogen (the feed rate of the jet mill is 5.0kg/h, the air pressure is 4.5×10 5 Pa), and the pellets are obtained The first mixed powder with diameter D90≤30μm;
(3)将所述第一混合粉末中加入研磨、过筛后的阿斯巴甜在球磨机中 粉碎混合15min,得到第二混合粉末;(3) the aspartame after grinding, sieving is added in the described first mixed powder and pulverized and mixed 15min in a ball mill to obtain the second mixed powder;
(4)将所述第二混合粉末中加入研磨、过筛后的玉米粉和碳酸钙在球 磨机中粉碎混合25min,得到第三混合粉末;(4) the corn flour after grinding, sieving and calcium carbonate are added to the second mixed powder and pulverized and mixed 25min in a ball mill to obtain the third mixed powder;
5)将所述第三混合粉末和EM菌粉按照等量递增法投入制粒机中混合 均匀,加入研磨、过筛后的硬脂酸镁和羧甲基纤维素钠,喷入聚山梨醇酯 80后混合均匀,即得兽用灭蝇预混剂。5) The third mixed powder and EM bacteria powder are dropped into the granulator according to the equal increment method and mixed, add the magnesium stearate and sodium carboxymethyl cellulose after grinding and sieving, and spray into the polysorbate After ester 80, mix evenly to obtain veterinary fly-killing premix.
实施例4Example 4
本实施例提供一种兽用灭蝇预混剂,该兽用灭蝇预混剂由如下组分组 成:除虫脲67g、EM菌粉6.7g、乳糖200g、枸橼酸50g、玉米粉300g、碳 酸钙226.3g、羧甲基纤维素钠75g、聚山梨醇酯80 25g和硬脂酸镁50g;This embodiment provides a veterinary fly-killing premix, which is composed of the following components: diflubenzuron 67g, EM bacteria powder 6.7g, lactose 200g, citric acid 50g, corn flour 300g , calcium carbonate 226.3g, sodium carboxymethyl cellulose 75g, polysorbate 80 25g and magnesium stearate 50g;
具体制备方法为:(1)将处方量的除虫脲、EM菌粉、乳糖、枸橼酸、 玉米粉、碳酸钙、羧甲基纤维素钠和硬脂酸镁分别进行研磨10min后过80 目筛备用;The concrete preparation method is: (1) Diflubenzuron, EM bacterial powder, lactose, citric acid, corn flour, calcium carbonate, sodium carboxymethyl cellulose and magnesium stearate of the recipe quantity are respectively ground for 10min and passed 80 minutes. Mesh sieve spare;
(2)将研磨、过筛后的除虫脲和乳糖通过干氮气输入到气流粉碎机中 (气流粉碎机进给速度是5.0kg/h,气压4.5×105Pa),得粒径D90≤30μm 第一混合粉末;(2) The diflubenzuron and lactose after grinding and sieving are input into the jet mill through dry nitrogen (the feed rate of the jet mill is 5.0kg/h, the air pressure is 4.5×10 5 Pa), and the particle size D90≤ 30μm first mixed powder;
(3)将所述第一混合粉末中加入研磨、过筛后的枸橼酸在球磨机中粉 碎混合15min,得到第二混合粉末;(3) the citric acid after grinding, sieving is added in the described first mixed powder and pulverized and mixed 15min in a ball mill to obtain the second mixed powder;
(4)将所述第二混合粉末中加入研磨、过筛后的玉米粉和碳酸钙在球 磨机中粉碎混合25min,得到第三混合粉末;(4) the corn flour after grinding, sieving and calcium carbonate are added to the second mixed powder and pulverized and mixed 25min in a ball mill to obtain the third mixed powder;
5)将所述第三混合粉末和EM菌粉按照等量递增法投入制粒机中混合 均匀,加入研磨、过筛后的硬脂酸镁和羧甲基纤维素钠,喷入聚山梨醇酯 80后混合均匀,即得兽用灭蝇预混剂。5) The third mixed powder and EM bacteria powder are dropped into the granulator according to the equal increment method and mixed, add the magnesium stearate and sodium carboxymethyl cellulose after grinding and sieving, and spray into the polysorbate After ester 80, mix evenly to obtain veterinary fly-killing premix.
实施例5Example 5
本实施例提供一种兽用灭蝇预混剂,该兽用灭蝇预混剂由如下组分组 成:除虫脲67g、EM菌粉6.7g、微晶纤维素200g、枸橼酸50g、玉米粉300g、 碳酸钙226.3g、聚乙烯醇75g、聚山梨醇酯80 25g和硬脂酸镁50g;This embodiment provides a veterinary fly-killing premix, which is composed of the following components: diflubenzuron 67g, EM bacterial powder 6.7g, microcrystalline cellulose 200g, citric acid 50g, Corn flour 300g, calcium carbonate 226.3g, polyvinyl alcohol 75g, polysorbate 80 25g and magnesium stearate 50g;
具体制备方法为:(1)将处方量的除虫脲、EM菌粉、微晶纤维素、枸 橼酸、玉米粉、碳酸钙、聚乙烯醇和硬脂酸镁分别进行研磨10min后过80 目筛备用;The concrete preparation method is: (1) Diflubenzuron, EM bacterial powder, microcrystalline cellulose, citric acid, corn flour, calcium carbonate, polyvinyl alcohol and magnesium stearate of the recipe quantity are respectively ground for 10min and then pass through 80 meshes. sieve spare;
(2)将研磨、过筛后的除虫脲和微晶纤维素通过干氮气输入到气流粉 碎机中(气流粉碎机进给速度是5.0kg/h,气压4.5×105Pa),得粒径D90≤ 30μm第一混合粉末;(2) The diflubenzuron and microcrystalline cellulose after grinding and sieving are input into the jet mill through dry nitrogen (the feed rate of the jet mill is 5.0kg/h, the air pressure is 4.5×10 5 Pa), and the pellets are obtained The first mixed powder with diameter D90≤30μm;
(3)将所述第一混合粉末中加入研磨、过筛后的枸橼酸在球磨机中粉 碎混合15min,得到第二混合粉末;(3) the citric acid after grinding, sieving is added in the described first mixed powder and pulverized and mixed 15min in a ball mill to obtain the second mixed powder;
(4)将所述第二混合粉末中加入研磨、过筛后的玉米粉和碳酸钙在球 磨机中粉碎混合25min,得到第三混合粉末;(4) the corn flour after grinding, sieving and calcium carbonate are added to the second mixed powder and pulverized and mixed 25min in a ball mill to obtain the third mixed powder;
5)将所述第三混合粉末和EM菌粉按照等量递增法投入制粒机中混合 均匀,加入研磨、过筛后的硬脂酸镁和聚乙烯醇,喷入聚山梨醇酯80后混 合均匀,即得兽用灭蝇预混剂。5) The third mixed powder and EM bacteria powder are dropped into the granulator according to the equal increment method and mixed, add the magnesium stearate and polyvinyl alcohol after grinding and sieving, and spray into the polysorbate 80 after Mix evenly to obtain veterinary fly control premix.
实施例6Example 6
本实施例提供一种兽用灭蝇预混剂,该兽用灭蝇预混剂由如下组分组 成:除虫脲67g、EM菌粉6.7g、微晶纤维素200g、枸橼酸50g、玉米粉300g、 碳酸钙226.3g、聚乙烯醇75g、无水乙醇25g和硬脂酸镁50g;This embodiment provides a veterinary fly-killing premix, which is composed of the following components: diflubenzuron 67g, EM bacterial powder 6.7g, microcrystalline cellulose 200g, citric acid 50g, Corn flour 300g, calcium carbonate 226.3g, polyvinyl alcohol 75g, anhydrous ethanol 25g and magnesium stearate 50g;
具体制备方法为:(1)将处方量的除虫脲、EM菌粉、微晶纤维素、枸 橼酸、玉米粉、碳酸钙、聚乙烯醇和硬脂酸镁分别进行研磨7min后过80 目筛备用;The concrete preparation method is: (1) Diflubenzuron, EM bacteria powder, microcrystalline cellulose, citric acid, corn flour, calcium carbonate, polyvinyl alcohol and magnesium stearate of the recipe quantity are respectively ground for 7min to pass 80 meshes. sieve spare;
(2)将研磨、过筛后的除虫脲和微晶纤维素通过干氮气输入到气流粉 碎机中(气流粉碎机进给速度是4.0kg/h,气压3.0×105Pa),得粒径D90≤ 30μm第一混合粉末;(2) The diflubenzuron and microcrystalline cellulose after grinding and sieving are input into the jet mill through dry nitrogen (the feed speed of the jet mill is 4.0kg/h, the air pressure is 3.0×10 5 Pa), and the pellets are obtained The first mixed powder with diameter D90≤30μm;
(3)将所述第一混合粉末中加入研磨、过筛后的枸橼酸在球磨机中粉 碎混合7min,得到第二混合粉末;(3) the citric acid after grinding, sieving is added in the described first mixed powder and pulverized and mixed 7min in a ball mill to obtain the second mixed powder;
(4)将所述第二混合粉末中加入研磨、过筛后的玉米粉和碳酸钙在球 磨机中粉碎混合20min,得到第三混合粉末;(4) corn flour after grinding, sieving and calcium carbonate are added to the second mixed powder and pulverized and mixed 20min in a ball mill to obtain the third mixed powder;
5)将所述第三混合粉末和EM菌粉按照等量递增法投入制粒机中混合 均匀,加入研磨、过筛后的硬脂酸镁和聚乙烯醇,喷入无水乙醇后混合均 匀,即得兽用灭蝇预混剂。5) The third mixed powder and EM bacteria powder are dropped into the granulator according to the equal increment method and mixed, add the magnesium stearate and polyvinyl alcohol after grinding and sieving, and mix after being sprayed into dehydrated alcohol. , that is, veterinary fly control premix.
对比例1Comparative Example 1
本对比例的预混剂的配方与实施例1相同,区别仅为制备方法不同, 本对比例的制备方法为:将除虫脲、EM菌粉、微晶纤维素、枸橼酸、玉米 粉、碳酸钙、羧甲基纤维素钠和硬脂酸镁分别过80目筛,然后将过筛后的 上述组分与聚山梨醇酯80混合均匀,得到预混剂。The formula of the premix of this comparative example is the same as that of Example 1, and the difference is only the preparation method. The preparation method of this comparative example is: diflubenzuron, EM bacteria powder, microcrystalline cellulose, citric acid, corn flour , calcium carbonate, sodium carboxymethyl cellulose and magnesium stearate are respectively sieved with 80 meshes, then the above-mentioned components after sieving are mixed with polysorbate 80 to obtain a premix.
对比例2Comparative Example 2
本对比例与实施例1的区别仅为去除6.7g的EM菌粉,并将除虫脲的 用量调整为73.7g,其他均同实施例1。The difference between this comparative example and Example 1 is only to remove the EM bacteria powder of 6.7g, and the consumption of diflubenzuron is adjusted to 73.7g, and others are the same as in Example 1.
对比例3Comparative Example 3
本对比例与实施例1的区别仅为将6.7g的EM菌粉和67g的除虫脲替 换为73.7g的环丙氨嗪,其他均同实施例1。The difference between this comparative example and Example 1 is only that the EM bacteria powder of 6.7g and the diflubenzuron of 67g are replaced by the cyromazine of 73.7g, and others are all the same as in Example 1.
测试例1Test Example 1
根据《中国药典》2015年版一部附录颗粒剂(冲剂)通则--0104颗粒剂的 质量要求,对本发明实施例1-6和对比例1-2制得的预混剂分别进行外观、 硬度、成粒率和含量进行检测,结果见下表1;According to "Chinese Pharmacopoeia" 2015 edition appendix granules (granules) general rule--0104 quality requirements of granules, the premixes prepared in Examples 1-6 of the present invention and Comparative Examples 1-2 were respectively tested for appearance, hardness, The granulation rate and content are tested, and the results are shown in Table 1 below;
表1不同预混剂质量检测结果Table 1 Quality test results of different premixes
由表1可知,本发明实施例1-6制得的预混剂含量均符合质量要求,含 量为标示量的99.0~102.0%。实施例1-6制得的预混剂外观、硬度、成粒 率均符合要求,并以实施例1、实施例3和实施例6制得的预混剂成粒率最 高,均达90%。对比例1因为混合不好,成粒率明显下降。As can be seen from Table 1, the contents of the premixes prepared in Examples 1-6 of the present invention all meet the quality requirements, and the contents are 99.0 to 102.0% of the indicated amount. The appearance, hardness and granulation rate of the premixes prepared in Examples 1-6 all meet the requirements, and the granulation rate of the premixes prepared in Example 1, Example 3 and Example 6 is the highest, all reaching 90% . In Comparative Example 1, the granulation rate decreased significantly because of poor mixing.
测试例2Test case 2
1、试验材料:实施例1制备的预混剂;实施例2制备的预混剂;对比 例2制备的预混剂;对比例3制备的预混剂。1. Test materials: the premix prepared in Example 1; the premix prepared in Example 2; the premix prepared in Comparative Example 2; the premix prepared in Comparative Example 3.
2、试验方法:选取某猪场商品猪100头,分为5组,每20头为一组。 A组为实施例1制备的预混剂饲喂组,B组为实施例2制备的预混剂饲喂组, C组为对比例2制备的预混剂饲喂组,D组为对比例3制备的预混剂饲喂组 和E组为空白对照组。动物分组及处理见下表2。2. Test method: Select 100 commercial pigs from a pig farm and divide them into 5 groups, with 20 pigs each as a group. Group A is the premix feeding group prepared in Example 1, Group B is the premix feeding group prepared in Example 2, Group C is the premix feeding group prepared in Comparative Example 2, and Group D is the comparative example 3 The prepared premix feeding group and E group were blank control group. Animal grouping and treatment are shown in Table 2 below.
表2试验动物分组及处理Table 2 Grouping and treatment of experimental animals
A组、B组、C组和D组从第6天开始分别饲喂实施例1制备的预混 剂、实施例2制备的预混剂、对比例2制备的预混剂和对比例3制备的预 混剂,连续7天。Group A, Group B, Group C and Group D were fed the premix prepared in Example 1, the premix prepared in Example 2, the premix prepared in Comparative Example 2, and the premix prepared in Comparative Example 3 from the sixth day, respectively. premix for 7 consecutive days.
各组分别在第1、3、5天(均未喂药)、第6、8、10、12天(使用药 物期间、第13、15、17、19天(停药后)采集猪粪。采集点应均匀分布。 把每组不同取样点的粪便混合并拌匀。每组每次的总取样量为1L。Pig feces were collected in each group on the 1st, 3rd, and 5th days (drug-free), 6th, 8th, 10th, and 12th days (during drug use, 13th, 15th, 17th, and 19th days (after drug withdrawal). The collection points should be evenly distributed. Mix the feces from different sampling points in each group and mix well. The total sampling volume of each group is 1L.
3、评价方法把每份样品分成6份分别放入6只200ml烧杯内,3. Evaluation method Divide each sample into 6 parts and put them into 6 200ml beakers respectively.
杯口用纱布封闭,放在温度25℃,湿度约60%的环境中培养3周。这 期间对出现的活蝇蛆和死蝇蛆进行计数,并计算每份样品的6只烧杯内蝇 蛆的平均死亡率和标准偏差。The mouth of the cup was closed with gauze, and cultured in an environment with a temperature of 25° C. and a humidity of about 60% for 3 weeks. During this period, live and dead fly maggots were counted, and the mean mortality and standard deviation of the fly maggots in the 6 beakers per sample were calculated.
4、结果与讨论4. Results and discussion
不同处理的猪粪便,蝇蛆平均死亡率见表3。对这些数据进行方差统计 分析。The average mortality of fly maggots in different treatments of pig manure is shown in Table 3. Statistical analysis of variance was performed on these data.
表3粪便中蝇蛆的死亡率(%)Table 3 Mortality (%) of fly maggots in feces
注:A-E组每列测试数据如果小写字母相同(均为a、b或c)表示差 异不显著(P>0.05),如果小写字母不同表示差异显著(P<0.05)。Note: If the lowercase letters of each column of test data in groups A-E are the same (all a, b or c), the difference is not significant (P>0.05), and if the lowercase letters are different, the difference is significant (P<0.05).
结果表明,A组和B组试验组在给药后当天至停药后3天、C组和D 组在给药后当天至停药后1天猪粪中蝇蛆均显示了100%的死亡率,与空白 对照组间差异显著(P<0.05)。The results showed that the test groups of group A and group B showed 100% death in pig feces from the day after administration to 3 days after drug withdrawal, and from the day after administration to 1 day after drug withdrawal in groups C and D. There was a significant difference between it and the blank control group (P<0.05).
A组、B组、C组和D组连用7天相比较,具有同样的临床控制蝇蛆 效果,差异不显著(P>0.05)。A组和B组较C组和D组的药效持续时间长, 因此,饲喂含EM菌粉和除虫脲的预混剂效果最优。而且使用本发明的预 混剂更方便更经济实惠。更重要的是,给猪饲喂环丙氨嗪,存在代谢产物 三聚氰胺残留的风险,但使用本发明所述的含EM菌粉和除虫脲的预混剂完全能够解决猪肉等食品中三聚氰胺残留的问题。Compared with group A, group B, group C and group D for 7 days, they have the same clinical effect of controlling fly maggots, and the difference is not significant (P>0.05). Group A and B had longer duration of drug effect than group C and D. Therefore, feeding the premix containing EM bacteria powder and diflubenzuron had the best effect. Moreover, it is more convenient and economical to use the premix of the present invention. More importantly, feeding cyromazine to pigs has the risk of residual melamine metabolite, but the use of the premix containing EM bacteria powder and diflubenzuron according to the present invention can completely solve the residual melamine in foods such as pork. The problem.
测试例3Test case 3
本测试例测试本发明的预混剂对于猪采食量的影响。This test example tests the effect of the premix of the present invention on pig feed intake.
选取同在一栋保育舍饲养的断奶仔猪8栏,每栏30头,并随机分为8 组,分别为空白组,对照组和加料组进行动物采食量测试:空白组每日日 粮为普通保育猪饲料,对照组为在普通保育猪饲料中加入约500ppm对比例 2制备的预混剂,加料组则在普通保育猪饲料中加入约500ppm本发明制备 产品含EM菌粉和除虫脲的预混剂。其中加料1-6组分别为按照本发明实施 例1-6所述方法制备的含EM菌粉和除虫脲的预混剂。Select 8 pens of weaned piglets raised in the same nursery, with 30 pigs in each pen, and randomly divide them into 8 groups, which are blank group, control group and feeding group for animal feed intake test: the daily diet of blank group is Common nursery pig feed, the control group is the premix prepared by adding about 500ppm in the common nursery pig feed in Comparative Example 2, and the feeding group adds about 500ppm in the common nursery pig feed The product prepared by the present invention contains EM bacteria powder and diflubenzuron premix. Wherein the feeding groups 1-6 are respectively the premix containing EM fungus powder and diflubenzuron prepared according to the method described in Examples 1-6 of the present invention.
按照常规对猪舍进行消毒,对猪采用高床漏缝饲养,使其自由采食、 饮水。按照上述方案连续饲喂14天,并在饲喂14天晨饲前,进行空腹称 重,计算日增重。本测试中普通保育猪饲料为以普通保育猪饲料的总重量 计,普通保育猪饲料由如下组分组成:玉米65wt%,膨化大豆8wt%,鱼粉 4wt%,乳清粉5wt%,代乳粉4wt%,发酵豆粕4wt%,豆粕4wt%,预 混料6wt%。The pig house was sterilized according to the routine, and the pigs were raised on a high bed with slats so that they could eat and drink freely. Continue feeding for 14 days according to the above-mentioned scheme, and before morning feeding for 14 days, carry out fasting weighing, and calculate daily weight gain. In this test, the common nursery pig feed is based on the total weight of the common nursery pig feed, and the common nursery pig feed is composed of the following components: 65wt% corn, 8wt% puffed soybean, 4wt% fish meal, 5wt% whey powder, milk replacer powder 4wt%, fermented soybean meal 4wt%, soybean meal 4wt%, premix 6wt%.
表4本发明的预混剂对于猪采食量的影响The influence of table 4 premix of the present invention on pig feed intake
表4中初重为未进行本饲喂测试前的重量,末重为在饲喂14天晨饲前, 进行空腹称重的重量。In Table 4, the initial weight is the weight before this feeding test is performed, and the final weight is the weight measured on an empty stomach before morning feeding for 14 days.
与空白组和对照组相比,加料组平均采食量大大提高,从而日增重也 明显提高,数据具有显著性差异,加料组1为本发明最佳实施例。Compared with the blank group and the control group, the average feed intake of the feeding group is greatly improved, so that the daily gain is also significantly improved, and the data has a significant difference, and the feeding group 1 is the best embodiment of the present invention.
以上已经描述了本发明的各实施例,上述说明是示例性的,并非穷尽 性的,并且也不限于所披露的各实施例。在不偏离所说明的各实施例的范 围和精神的情况下,对于本技术领域的普通技术人员来说许多修改和变更 都是显而易见的。Various embodiments of the present invention have been described above, and the foregoing descriptions are exemplary, not exhaustive, and not limiting of the disclosed embodiments. Numerous modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010598698.7A CN111903701A (en) | 2020-06-28 | 2020-06-28 | A kind of veterinary fly-killing premix and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010598698.7A CN111903701A (en) | 2020-06-28 | 2020-06-28 | A kind of veterinary fly-killing premix and its preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111903701A true CN111903701A (en) | 2020-11-10 |
Family
ID=73226660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010598698.7A Pending CN111903701A (en) | 2020-06-28 | 2020-06-28 | A kind of veterinary fly-killing premix and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111903701A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111700863A (en) * | 2020-08-12 | 2020-09-25 | 武汉轻工大学 | A kind of veterinary diflubenzuron premix and preparation method thereof |
CN114145311A (en) * | 2021-12-01 | 2022-03-08 | 武汉回盛生物科技股份有限公司 | Diflubenzuron particles and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107996846A (en) * | 2017-11-30 | 2018-05-08 | 驻马店华中正大有限公司 | A kind of mixed feed additive for animals and preparation method and application |
CN108187027A (en) * | 2018-03-30 | 2018-06-22 | 内蒙古拜克生物有限公司 | A kind of enramycin premix and preparation method thereof |
-
2020
- 2020-06-28 CN CN202010598698.7A patent/CN111903701A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107996846A (en) * | 2017-11-30 | 2018-05-08 | 驻马店华中正大有限公司 | A kind of mixed feed additive for animals and preparation method and application |
CN108187027A (en) * | 2018-03-30 | 2018-06-22 | 内蒙古拜克生物有限公司 | A kind of enramycin premix and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
左三龄等: "HPLC法测定兽用除虫脲原料药含量及有关杂质", 《中国兽药杂志》 * |
李济宸等: "《菌糠饲料生产及使用技术》", 30 June 2006 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111700863A (en) * | 2020-08-12 | 2020-09-25 | 武汉轻工大学 | A kind of veterinary diflubenzuron premix and preparation method thereof |
CN114145311A (en) * | 2021-12-01 | 2022-03-08 | 武汉回盛生物科技股份有限公司 | Diflubenzuron particles and preparation method and application thereof |
CN114145311B (en) * | 2021-12-01 | 2024-05-03 | 武汉回盛生物科技股份有限公司 | Diflubenzuron particles, and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101129478B (en) | Wormkillers of methylamino avermectin benzoate for animals, method of preparing the same and application of the same | |
CN102273449B (en) | Avermectin-cyanobacteria anti-ultraviolet sustained-release microcapsule water dispersible granules, and preparation method thereof | |
CN101999348B (en) | Preparation method of pesticide effervescent tablet | |
CN111903701A (en) | A kind of veterinary fly-killing premix and its preparation method and application | |
CN104922073A (en) | Soluble florfenicol powder and preparation method thereof | |
CN110124580A (en) | A kind of tea tree ethereal oil enteric-coated pellets and its preparation method and application | |
CN109329610A (en) | A kind of feed addictive and preparation method thereof for pig | |
CN102550831B (en) | Cinnamic acid improves the application in the product of growth of animals or poultry performance in preparation | |
CN104770383A (en) | Weeding composition containing tebuthiuron and bromacil and applications of weeding composition | |
CN105746563B (en) | A kind of pleocidin and athomin complex composition and its application | |
CN103739394A (en) | Biogas liquid compounded fungicide for preventing and treating gray mold | |
US7067161B2 (en) | Animal food supplement compositions and methods of use | |
CN114982767A (en) | Efficient mosquito and fly killing preparation and preparation method thereof | |
CN116267980A (en) | Insecticidal composition capable of actively attracting and locally applying drugs and application | |
CN111700863A (en) | A kind of veterinary diflubenzuron premix and preparation method thereof | |
CN104982453A (en) | Insect and bacterium killing granula with dinotefuran | |
CN101317568A (en) | Tetonadiclofen water-dispersible granule and preparation method thereof | |
CN118340728B (en) | A kind of composite lincomycin hydrochloride soluble powder and preparation method thereof | |
CN112088835A (en) | Ecological pig raising method | |
CN109999014A (en) | It is a kind of can the new merit chigger disease of prevention and control plants essential oil and preparation method thereof | |
JP2016208923A (en) | Feed additive and feed having the additive added thereto | |
CN105309441B (en) | Composition pesticide containing nitrile pyrrole mite ester and its purposes in prevention and treatment harmful mite | |
CN105594727B (en) | Composition, Preparation method and use containing MTI-446 and 2-cyano-3-amino-3-phenylancryic acetate | |
CN117751952A (en) | Efficient diflubenzuron premix and preparation method thereof | |
CN114425069B (en) | Special forage grass formula for preventing male forest musk lithiasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201110 |